摘要 |
The present invention is directed to a novel method for the treatment of diseases by activating the unfolded protein response (UPR), or of inhibiting the expression of the inducible isoform of the nitric oxide synthase (iNOS) enzyme, or both. New methylpyrazole compounds which activate the UPR, downregulate iNOS, and reduce inflammatory markers are disclose herein, as are compositions comprising said compounds and their applications as pharmaceuticals for the treatment of disease. |
申请人 |
KALYPSYS, INC.;HASSIG, CHRISTIAN;GAHMAN, TIMOTHY, C.;HERBERT, MARK, R.;THAYER, ANGELINA, M. |
发明人 |
HASSIG, CHRISTIAN;GAHMAN, TIMOTHY, C.;HERBERT, MARK, R.;THAYER, ANGELINA, M. |